PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progeny

Mohammad A. Alzubi(Johns Hopkins University), Alan D. Friedman(Johns Hopkins University)
Cancer Immunology Immunotherapy
February 4, 2025
Cited by 1


Related Papers